Literature DB >> 15871291

[Functional outcomes of transoral laser surgery of supraglottic carcinoma].

R Cabanillas1, C Ortega, J P Rodrigo, J L Llorente, P Ortega, C Suárez.   

Abstract

OBJECTIVES: To analyse the functional outcome of patients with supraglottic carcinomas treated by transoral laser surgery.
METHODS: The clinical records of 55 patients who underwent transoral laser surgery were reviewed. Swallowing capacity, surgical complications, requirements for tracheotomies, percentage of decannulations, laryngeal paralysis, stenosis, aspiration associated pneumonia, time to remove the nasogastric tube and postsurgical stay in hospital were the studied variables.
RESULTS: 52% of the patients had a normal or within functional limits swallowing performance. 18% suffered aspiration pneumonia. 13% developed a laryngeal stenosis. 7% suffered of laryngeal palsy. 18 tracheostomies were performed, of them 10 could be reverted. The mean time to remove the nasogastric tube was 9 days. The mean hospital stay was 23 days.
CONCLUSIONS: The main functional advantages of transoral laser surgery for supraglottic carcinoma, when compared with the conventional approach, are a lower incidence of temporary tracheotomies, a faster removal of the nasogastric feeding tube, and a lower incidence of pharyngocutaneous fistulas (0%).

Entities:  

Mesh:

Year:  2005        PMID: 15871291     DOI: 10.1016/s0001-6519(05)78592-7

Source DB:  PubMed          Journal:  Acta Otorrinolaringol Esp        ISSN: 0001-6519


  2 in total

1.  Long Term Oncological Results of Transoral Laser Microsurgery for Early and Moderately Advanced Glottic Carcinoma in Primary and Salvage Settings.

Authors:  Prem Sagar; Rajeev Kumar; Richa Vaish; Alok Thakar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-09-29

Review 2.  Transoral laser microsurgery for laryngeal cancer: a primer and review of laser dosimetry.

Authors:  Marc Rubinstein; William B Armstrong
Journal:  Lasers Med Sci       Date:  2010-09-11       Impact factor: 3.161

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.